Skip to main content

Kimberly-Clark and Suzano To Create Global Tissue Company

Liz Dominguez
Kleenex

Kimberly-Clark is creating a new global tissue company that will manufacture, market and distribute products such as toilet paper, facial tissues, paper towels and napkins through a joint venture with Brazilian pulp company Suzano. 

The $3.4 billion deal brings together Kimberly-Clark’s portfolio of consumer and professional tissue brands with Suzano’s industrial manufacturing efficiency.

This is part of ongoing restructuring efforts initially announced last year. The company is reorganizing into three main business areas and shoring up its supply chain to support efforts and cut costs. 

More: Learn how the company is optimizing its collaborative supply chain amid the costly tariff environment

"This transaction is a powerful step forward in the transformation strategy we laid out last year," said Kimberly-Clark CEO Mike Hsu in a statement, who added that the investment will help the company focus its portfolio on higher-growth, higher-margin businesses.

Advertisement - article continues below
Advertisement

About the New Company

Kimberly-Clark is licensing out three consumer brands — Scott, Kleenex and Viva — under a long-term agreement that also includes offloading nearly all the assets of the company’s international family care and professional portfolio. Additionally, the new entity will own 40 regional brands, among them are Andrex, Scottex, Hakle, Page and Suave. 

The products will be sold across more than 70 countries, encompassing 22 manufacturing facilities — including in Europe, Asia, the Middle East, South America, Central America, Africa and Oceania — and an estimated 9,000 employees. The company will be based in the Netherlands.

Kimberly-Clark will retain a 49% stake of the new company, while Suzano takes majority ownership at 51%, paying $1.734 billion for its part. Kimberly-Clark's interests in Mexico and its joint venture in South Korea are outside the scope of this partnership.

The deal is expected to finalize in mid-2026 and Kimberly-Clark will retain its consumer tissue and professional businesses in the U.S. 

More Like This

X
This ad will auto-close in 10 seconds